These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2135223)

  • 1. An M1-selective muscarinic receptor antagonist telenzepine improves lung function in patients with chronic obstructive bronchitis.
    Cazzola M; D'Amato G; Guidetti E; Staudinger H; Steinijans VW; Kilian U
    Pulm Pharmacol; 1990; 3(4):185-9. PubMed ID: 2135223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muscarinic M1-receptor-selective antagonist, telenzepine, had no bronchodilatory effects in COPD patients.
    Ukena D; Wehinger C; Engelstätter R; Steinijans V; Sybrecht GW
    Eur Respir J; 1993 Mar; 6(3):378-82. PubMed ID: 8472828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.
    Cazzola M; Matera MG; Liccardi G; Sacerdoti G; D'Amato G; Rossi F
    Pulm Pharmacol; 1994 Apr; 7(2):91-7. PubMed ID: 8081076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the M1-selective telenzepine on esophageal acid exposure in healthy volunteers.
    Stockbrügger RW; Armbrecht U; Reul W
    Z Gastroenterol; 1988 Jun; 26(6):297-302. PubMed ID: 3061181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
    Poli E; Monica B; Zappia L; Pozzoli C; Bertaccini G
    Gen Pharmacol; 1992 Jul; 23(4):659-64. PubMed ID: 1397972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans.
    Nelson DK; Glasbrenner B; Dahmen G; Riepl RL; Malfertheiner P; Adler G
    Am J Physiol; 1996 Nov; 271(5 Pt 1):G824-30. PubMed ID: 8944697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status and future perspectives of muscarinic receptor antagonists.
    Londong W
    Scand J Gastroenterol Suppl; 1986; 125():55-60. PubMed ID: 2881347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
    Coruzzi G; Adami M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G; Küppers U; Singer MV
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exocrine pancreatic secretion in man following one week of M1-muscarinic receptor blockade.
    Malfertheiner P; Nelson DK; Kemmer TP; Glasbrenner B; Schneider A; Ditschuneit H
    Aliment Pharmacol Ther; 1993 Aug; 7(4):423-8. PubMed ID: 8218757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.
    Galvan M; Boer R; Schudt C
    Eur J Pharmacol; 1989 Aug; 167(1):1-10. PubMed ID: 2776837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.
    Fryer AD; el-Fakahany EE
    Life Sci; 1990; 47(7):611-8. PubMed ID: 2402185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.
    Quinn D; Barnes CN; Yates W; Bourdet DL; Moran EJ; Potgieter P; Nicholls A; Haumann B; Singh D
    Pulm Pharmacol Ther; 2018 Feb; 48():71-79. PubMed ID: 28987804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV
    Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone.
    Armbrecht U; Reul W; Stockbrügger RW
    Z Gastroenterol; 1990 Feb; 28(2):85-9. PubMed ID: 2181787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.
    Londong W; Londong V; Meierl A; Voderholzer U
    Gut; 1987 Jul; 28(7):888-95. PubMed ID: 3653758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of muscarinic receptors in murine airways.
    Garssen J; Van Loveren H; Gierveld CM; Van der Vliet H; Nijkamp FP
    Br J Pharmacol; 1993 May; 109(1):53-60. PubMed ID: 8495246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and tolerability of telenzepine in patients with compensated liver cirrhosis].
    Reinicke A; Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1990 Nov; 40(11):1239-41. PubMed ID: 2085337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.
    Kromer W; Baron E; Boer R; Eltze M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):7-13. PubMed ID: 2030745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M
    Eur J Pharmacol; 1990 May; 180(1):161-8. PubMed ID: 2365000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.